Altimmune Inc
Statements
Cash Flow
Altimmune Inc (ALT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -24 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 111 | 83 | -7.1 | -4.1 | -4.3 | -4.8 | -3.6 | 0.3 | -1.0 | -5.2 | -2.1 | -3.1 | -2.4 | -2.0 | -4.3 | -7.2 | -9.5 | -13 | -20 | -19 | -18 | -22 | -14 | -17 | -15 | -17 | -19 | -19 | -20 | -17 | -16 | -18 | -27 | -18 | -17 | -19 | -12 | -19 | -21 | -24 | -77 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.3 | 0.1 | 0.1 | 0.1 | -0.1 | -0.2 | 0.1 | 0.1 | -0.6 | 1.9 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| 1.5 | 0.3 | 0.1 | 0.6 | 0.5 | – | 0.4 | 0.3 | 0.1 | – | 0.4 | 0.3 | 0.3 | 0.3 | 0.2 | 0.3 | 1.3 | 0.7 | 1.2 | 1.5 | 1.5 | 1.3 | 2.0 | 2.0 | 2.1 | 1.9 | 2.7 | 2.8 | 2.7 | 2.5 | 3.7 | 4.3 | 3.1 | 3.4 | 4.0 | 3.6 | 3.6 | 4.9 | 3.4 | 2.8 | 15 | |
| 1.9 | 0.7 | 0.2 | 0.5 | 27 | 6.7 | -1.2 | 4.5 | -2.4 | 19 | 0.4 | 0.4 | 7.7 | 0.3 | 2.0 | 12 | 10.0 | -5.3 | 2.1 | 8.5 | 3.5 | 4.4 | 0.1 | 3.9 | 2.1 | 2.1 | 2.7 | 2.7 | 2.7 | – | – | – | – | – | – | – | – | – | – | – | – | |
| 0.3 | 4.3 | -5.1 | 0.8 | -2.0 | -2.3 | 0.3 | 3.9 | 2.0 | 31 | -0.5 | -0.1 | 0.7 | 1.8 | -2.5 | -2.7 | -1.8 | 2.4 | -6.9 | -2.7 | 12 | -2.6 | 5.6 | -0.5 | 6.5 | 2.5 | -1.6 | -5.5 | -2.0 | 0.8 | 5.3 | 3.2 | -8.4 | 2.5 | 0.1 | -0.5 | 3.5 | 3.6 | -2.0 | -4.3 | 0.9 | |
| 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.7 | 0.2 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 | 0.1 | 4.3 | 7.8 | 0.1 | 0.2 | 0.0 | 0.0 | 0.1 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| -67 | 0.0 | 67 | -53 | 0.0 | 0.0 | -0.7 | -0.2 | -0.2 | 0.0 | 0.0 | 0.0 | -28 | -0.1 | 6.6 | 6.1 | -48 | -37 | 19 | 25 | 18 | 25 | 0.0 | -49 | -25 | 1.0 | 13 | 4.0 | 4.4 | -8.0 | -40 | -3.7 | 1.2 | 14 | -5.1 | 101 | -149 | -79 | -3.7 | -221 | -454 | |
| 0.0 | 0.0 | 200 | 0.0 | 0.0 | 0.0 | 200 | 0.0 | 0.0 | – | 28,154 | – | – | 3,809 | – | – | – | 135 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| 1.3 | 2.0 | 2.3 | 0.0 | 13 | 0.0 | 0.0 | -3.5 | 0.0 | 0.0 | 0.0 | 13 | 0.0 | 3,791 | 0.1 | 54 | 13 | 135 | 0.1 | 18 | 0.1 | 224 | 0.1 | -0.3 | -0.1 | -0.1 | -0.5 | -0.5 | 0.0 | 0.0 | -0.6 | -0.2 | 1.1 | – | 0.2 | – | 0.1 | – | 0.2 | – | – | |
| – | -0.1 | 2.8 | 2.8 | – | 2.8 | -1.5 | -1.5 | -1.5 | -1.5 | -0.2 | -0.2 | 0.0 | -0.1 | 0.6 | 0.6 | -0.6 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0 | – | – | – | 0.4 | 20 | – | – | – | |
| 1.3 | 2.0 | -198 | 201 | 13 | 16 | 0.0 | -3.5 | 4.4 | 32 | 13 | -0.2 | -0.1 | 0.0 | 0.1 | 55 | 136 | 23 | 34 | 18 | 0.1 | 13 | 3.2 | 22 | 32 | 0.0 | -0.3 | 13 | 0.6 | 73 | -0.3 | 0.0 | 0.3 | 10 | 34 | 52 | 39 | 81 | 78 | 211 | 410 | |
| 46 | 85 | -138 | -7.4 | 8.7 | -4.8 | -4.2 | -3.3 | 3.2 | 26 | 11 | -3.2 | -31 | -2.0 | 2.3 | 53 | 79 | -28 | 34 | 24 | 0.8 | 15 | -10 | -44 | -8.4 | -16 | -6.4 | -2.3 | -15 | 48 | -56 | -22 | -26 | 5.5 | 12 | 134 | -122 | -17 | 54 | -35 | -120 | |
| 111 | 83 | -7.1 | -4.1 | -4.3 | -4.8 | -4.2 | 0.2 | -1.2 | -5.2 | -2.1 | -3.1 | -2.4 | -2.0 | -4.4 | -7.3 | -9.6 | -14 | -24 | -27 | -18 | -22 | -14 | -17 | -15 | -17 | -19 | -19 | -20 | -17 | -16 | -18 | -27 | -18 | -17 | -19 | -12 | -19 | -21 | -24 | -77 |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.